Form 8-K - Current report:
SEC Accession No. 0001193125-19-297010
Filing Date
2019-11-21
Accepted
2019-11-21 06:57:19
Documents
15
Period of Report
2019-11-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d817874d8k.htm   iXBRL 8-K 35006
2 EX-99.1 d817874dex991.htm EX-99.1 47694
7 GRAPHIC g817874g1121085319745.jpg GRAPHIC 3792
  Complete submission text file 0001193125-19-297010.txt   263808

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amgn-20191121.xsd EX-101.SCH 4549
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20191121_def.xml EX-101.DEF 13775
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20191121_lab.xml EX-101.LAB 22823
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20191121_pre.xml EX-101.PRE 14744
13 EXTRACTED XBRL INSTANCE DOCUMENT d817874d8k_htm.xml XML 6351
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 191235688
SIC: 2836 Biological Products, (No Diagnostic Substances)